Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-12-23 00:00:00 ET · period of report 2022-12-21 · accession 0001127602-22-028247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-23 | 2022-12-21+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.68 | -402.6K | 17.99M | -2% | -$676.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-21 | S | D | 193,211 | $1.70 | 18,200,389 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-12-22 | S | D | 209,385 | $1.66 | 17,991,004 | D | — | — |